These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1034 related items for PubMed ID: 34538770
41. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study. Lenis AT, Pooli A, Lec PM, Sadun TY, Johnson DC, Lebacle C, Fendler WP, Eiber M, Czernin J, Reiter RE, Calais J. Eur Urol Oncol; 2022 Oct; 5(5):544-552. PubMed ID: 32958451 [Abstract] [Full Text] [Related]
42. Pelvic lymph node dissection in prostate cancer. Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE. Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079 [Abstract] [Full Text] [Related]
46. 68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer. Klingenberg S, Jochumsen MR, Ulhøi BP, Fredsøe J, Sørensen KD, Borre M, Bouchelouche K. J Nucl Med; 2021 Feb; 62(2):214-220. PubMed ID: 32444374 [Abstract] [Full Text] [Related]
47. A comparison between 68Ga-labeled prostate-specific membrane antigen-PET/CT and multiparametric MRI for excluding regional metastases prior to radical prostatectomy. Frumer M, Milk N, Rinott Mizrahi G, Bistritzky S, Sternberg I, Leibovitch I, Dekel Y, Amiel GE, Zisman A, Baniel J, Haifler M, Gal J, Hoffman A, Sagy I, Rosenzweig B, Haramaty R, Golan S. Abdom Radiol (NY); 2020 Dec; 45(12):4194-4201. PubMed ID: 32671440 [Abstract] [Full Text] [Related]
49. Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer. Gondoputro W, Scheltema MJ, Blazevski A, Doan P, Thompson JE, Amin A, Geboers B, Agrawal S, Siriwardana A, Van Leeuwen PJ, van Oosterom MN, Van Leeuwen FWB, Emmett L, Stricker PD. J Nucl Med; 2022 Nov; 63(11):1659-1664. PubMed ID: 35241483 [Abstract] [Full Text] [Related]
50. A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer. Mari A, Cadenar A, Giudici S, Cianchi G, Albisinni S, Autorino R, Di Maida F, Gandaglia G, Mir MC, Valerio M, Marra G, Zattoni F, Bianchi L, Lombardo R, Shariat SF, Roupret M, Bauckneht M, Vaggelli L, De Nunzio C, Minervini A. Prostate Cancer Prostatic Dis; 2024 May 31. PubMed ID: 38822051 [Abstract] [Full Text] [Related]
51. Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review. Mattana F, Muraglia L, Rajwa P, Zattoni F, Marra G, Chiu PKF, Heidegger I, Kasivisvanathan V, Kesch CV, Olivier J, Preisser F, Thibault C, Valerio M, van den Bergh RCN, Gandaglia G, Ceci F, European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Eur Urol Oncol; 2023 Apr 31; 6(2):128-136. PubMed ID: 36804735 [Abstract] [Full Text] [Related]